Unger, J. M., Vaidya, R., Albain, K. S., LeBlanc, M. L., Minasian, L. M., Gotay, C., … Hershman, D. L. (2019). Sex differences in adverse event reporting in SWOG chemotherapy, biologic/immunotherapy, and targeted agent cancer clinical trials. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 37).

Unger, Joseph M., Riha Vaidya, Kathy S. Albain, Michael Leo LeBlanc, Lori M. Minasian, Carolyn Gotay, Norah Lynn Henry, et al. “Sex differences in adverse event reporting in SWOG chemotherapy, biologic/immunotherapy, and targeted agent cancer clinical trials.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 37, 2019.

Unger JM, Vaidya R, Albain KS, LeBlanc ML, Minasian LM, Gotay C, et al. Sex differences in adverse event reporting in SWOG chemotherapy, biologic/immunotherapy, and targeted agent cancer clinical trials. In: JOURNAL OF CLINICAL ONCOLOGY. 2019.

Unger, Joseph M., et al. “Sex differences in adverse event reporting in SWOG chemotherapy, biologic/immunotherapy, and targeted agent cancer clinical trials.” JOURNAL OF CLINICAL ONCOLOGY, vol. 37, no. 15, 2019.

Unger JM, Vaidya R, Albain KS, LeBlanc ML, Minasian LM, Gotay C, Henry NL, Fisch MJ, Ramsey SD, Blanke CD, Lyman GH, Hershman DL. Sex differences in adverse event reporting in SWOG chemotherapy, biologic/immunotherapy, and targeted agent cancer clinical trials. JOURNAL OF CLINICAL ONCOLOGY. 2019.